India: Bombay High Court Holds That Feranta Not Deceptively Similar To Intas Ferintas

Last Updated: 29 June 2017
Article by S.S. Rana & Co. Advocates

In a recent case filed by Ajanta Pharma Ltd (hereinafter referred to as the "Plaintiff") before the Bombay High Court (hereinafter referred to as the 'Court') seeking an injunction restraining Theon Pharmaceuticals (hereinafter referred to as 'Defendant No. 1') and Intas Pharmaceuticals (hereinafter referred to as 'Defendant No. 2') (collectively referred to as the Defendants) from infringing and passing off its mark "FERANTA", the Hon'ble Court vide order dated May 5, 2017 held that there was no prima facie case made out by the Plaintiff, and dismissed the present notice of motion filed by it against the Defendants.

Brief Facts:

The Plaintiff obtained for registration of the mark FERANTA under Application no. 1652066, on February11, 2008 in class 05 for pharmaceutical, medicinal and veterinary preparations. The Plaintiff has used the mark since 2013 for L-Methyfolate Calcium, Pyridoxal 5'- Phosphate, Methylcobalamin, Ferrous Ascorbate and Zinc Sulphate pharmaceutical tablets. The Plaintiff claims that it has had considerable sales of INR 88.21 lakhs (USD 136805 approx.) in 2015-16, and has run up promotional costs as well. The Plaintiff claims that in or around July, 2016, it discovered the Defendant No. 2's Ferrous Ascorbate and L-Methyl Folate tablet under the FERINTA mark (now abandoned), with a suffix 'XT', which was being sold as a dietary supplement. It further discovered that the Defendant No. 2 had applied for registration of its mark under application number 2969381, in the same class as that of the Plaintiff. The Registrar objected to the application, citing the Plaintiff's prior registration of FERANTA as a conflicting mark. On that objection, the Defendant No. 2 made another application on April 15, 2016 under no. 3235362 for the mark FERINTA XT. On August 11, 2016, the Hon'ble Court granted ex-parte ad interim injunction in favour of the Plaintiff directing the Defendant No. 2 to cease usage of FERINTA. On September 1, 2016, the Defendant No. 2 agreed to cease usage of FERINTA, and would instead use the mark INTAS' FERINTAS, with INTAS' set above the word FERINTAS, with the letter FER in black, and the rest in a rust red color and FERINTAS set in an oval lozenge device.

Defense taken by the Defendants:

  • That the Plaintiff has itself copied the trade mark from another party, and therefore cannot institute action against the Defendant No. 2.
  • That the Plaintiff's products are sold as pharmaceutical drugs, whereas the Defendant's products are sold as dietary supplements.
  • There is honesty in adoption of the trade mark, with FER- being derived from FERrous, and INTAS from the Company name.
  • That the present case does not fall under the ambit of Section 29 (1) but rather Section 29 (2) of the Trade Marks Act, 1999. The goods manufactured by the Plaintiff and the Defendant No. 2 cannot be conflated as Class 05 has a wide sweep, as if a party has only manufactured pharmaceutical drugs and not dietary supplements, there cannot be any likelihood of confusion. In other words, for a case falling under Section 29 (2) of the Trade Marks Act, 1999, mere similarity of marks is insufficient, and must be accompanied by a similarity or identity of goods; and even that will not completely fulfil the requirements of Section 29 (2), for a likelihood of confusion must be shown.

Plaintiff's Counter-Submissions:

  • That the Plaintiff has not copied anyone's mark, and the mark FERANTA lapsed in 1989 and was filed on a proposed to be used basis.
  • That the two products have precisely the same ingredients and serve exactly the same purpose. According to the Nice classification, pharmaceuticals include dietary and meal supplements and dietetic foods adapted for medicinal use (but, importantly, does not include meal supplements and dietetic foods not for medicinal use).
  • The contents or ingredients are the same, as are the trade and marketing channels and the consumer base. Any difference is formulation is trivial, as both products are vended to treat anemia.
  • The Plaintiff states that a party cannot slither around in Class 05 by saying its mark, though in that class, is for a different sub-class or sub-species. The test in law speaks to the existence of rival marks in a class, not in a sub-classification. A classification or sub-classification in any case is never as important as the manner of use. What the law prevents is a rival from adopting a deceptively similar mark.
  • That honesty in adoption is irrelevant, and in any case, there is no honesty on the part of the Defendant for adoption of the said mark, as the Defendant was well aware of the Plaintiff's prior registration and its mark inter alia from the Registrar's citing of the Plaintiff's mark as a conflicting mark.
  • The Plaintiff submits that the deconstruction of the mark into separate names and explaining how the trade mark is formed is wholly irrelevant to the present case.

Court's Observations:

  • The Court observes that the two marks have to be seen as a whole and not separately. Therefore, the Plaintiff's submission that the Defendant's mark should be considered without INTAS is dismissed. Furthermore, the Court held that looking at the two marks as a whole, there is no doubt that there is, in the words of the Supreme Court in JR Kapoor v Micronix India [1994 Supp (3) SCC 215] not the remotest chance of buyers and users being misguided or confused.
  • The Hon'ble Court observed that one must guard as much against an approach that is overbroad, and sweeps in all manner of goods easily distinguished, and one that is much too narrow. Given the similarity of marks, the next step would then be to test similarity of goods. The Defendant No. 2's product is not adapted for medical use. The Hon'ble Court further observed that the NICE classification (2016 version, 10th edition), in its entry for Class 5, says the class does not include meal replacements, dietetic food and beverages not for medical or veterinary use. If the Defendant No. 2's product is such a dietetic food, then that may be another point of distinction. The Hon'ble Court held that the two marks were sufficiently distinguishable.
  • The Hon'ble Court observed that the Defendant's products did not harm the public in general and did not warrant an injunction to preserve the public interest.
  • The Hon'ble Court also observed that there is a well-established sequence in which a claim in infringement and passing off (or either) should be examined. Though the causes of action are distinct, some of their tests overlap common to both is this sequencing:

    • Are the marks identical?
    • If not, are they similar;
    • What is the nature and degree of similarity;
    • What goods or services are they being used on or for?
    • Are those goods or services identical, or similar?

The Hon'ble Court stated that answers to these questions, in various permutations, yield a result. However, the Hon'ble Court stated that it is possible to invert this paradigm, and suggest that because the goods are either the same or similar, therefore one must work backwards to conclude that the marks must be similar, or held to be similar, and therefore, infringement and passing off must both be presumed. Identity or similarity of marks must be the first test, not the assumption, and we proceed to the goods or services from there, not the other way around.

Held:

"It is not possible to hold that a prima facie case is made out. The Motion fails. It is dismissed. There will be no order as to costs."

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
S.S. Rana & Co. Advocates
 
In association with
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.